News AFT Pharmaceuticals Limited

Equities

AFT

NZAFTE0001S4

End-of-day quote New Zealand S.E. Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
3.14 ^NZD	+2.61%		-2.79%	-10.29%

Mar. 04	New Zealand Shares Close Flat on Monday; Fletcher Building Chair Steps Down	MT
Mar. 04	AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

New Zealand Shares Close Flat on Monday; Fletcher Building Chair Steps Down	Mar. 03	MT
AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals	Mar. 03	MT
Aft Expands Its Co-Operation with Hikma Pharmaceuticals	Mar. 03	CI
New Zealand Shares Rebound on Friday Close; AFT Pharmaceuticals Raises Operation Profit Guidance	Feb. 15	MT
AFT Pharmaceuticals Boosts Operating Profit Guidance for Fiscal Year 2024	Feb. 15	MT
AFT Pharmaceuticals Limited Updates Earnings Guidance for the Fiscal Year 2024	Feb. 15	CI
AFT Pharmaceuticals' Licensee Launches Pain Relief Medication in US; Shares Rise 4%	Feb. 06	MT
AFT Pharmaceuticals’ Maxigesic IV Launches in the US	Feb. 05	MT
AFT Pharmaceuticals Ties Up with Belgian Firm to Develop Skin Medication	Jan. 18	MT
Hyloris Pharmaceuticals SA Enters into Partnership with AFT Pharmaceuticals to Develop a Novel Mucoadhesive Film for the Treatment of Vulvar Lichen Sclerosus	Jan. 18	CI
AFT Pharmaceuticals Ties Up with Hyloris to Develop Burning Mouth Syndrome Treatment Candidate	Dec. 21	MT
AFT Pharmaceuticals Limited Enters into Partnership with Hyloris Pharmaceuticals	Dec. 21	CI
France keeps 2024 bond issuance steady at 285 bln euros	Dec. 13	RE
AFT Pharmaceuticals Limited Reaffirms Earnings Guidance for the Fiscal Year 2024	Nov. 22	CI
Transcript : AFT Pharmaceuticals Limited, H1 2024 Earnings Call, Nov 23, 2023	Nov. 22
AFT Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 22	CI
AFT Pharmaceuticals Secures Clearance to Sell Antiseptic Ointment in China	Nov. 21	MT
AFT Pharmaceuticals : Annual Meeting Minutes 2023	Nov. 01	PU
Hyloris Pharma wins US FDA approval for pain treatment	23-10-18	RE
AFT Pharmaceuticals Secures US FDA Approval for Sale of Intravenous Pain Relief Drug	23-10-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AFT Pharmaceuticals Limited

Equities

AFT

NZAFTE0001S4

Summary

Filters